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Abstract
Background:  Surgical site infections (SSI) remain a major clinical problem in terms of morbidity,
mortality, and hospital costs. Nearly 60% of SSI diagnosis occur in the postdischarge period. However,
literature provides little information on risk factors associated to in-hospital and postdischarge SSI
occurrence. A national prospective multicenter study was conducted with the aim of assessing the
incidence of both in-hospital and postdisharge SSI, and the associated risk factors.
Methods: In 2002, a one-month, prospective national multicenter surveillance study was conducted in
General and Gynecological units of 48 Italian hospitals. Case ascertainment of SSI was carried out using
standardized surveillance methodology. To assess potential risk factors for SSI we used a conditional
logistic regression model. We also reported the odds ratios of in-hospital and postdischarge SSI.
Results: SSI occurred in 241 (5.2%) of 4,665 patients, of which 148 (61.4%) during in-hospital, and 93
(38.6%) during postdischarge period. Of 93 postdischarge SSI, sixty-two (66.7%) and 31 (33.3%) were
detected through telephone interview and questionnaire survey, respectively. Higher SSI incidence rates
were observed in colon surgery (18.9%), gastric surgery (13.6%), and appendectomy (8.6%). If considering
risk factors for SSI, at multivariate analysis we found that emergency interventions, NNIS risk score, pre-
operative hospital stay, and use of drains were significantly associated with SSI occurrence. Moreover, risk
factors for total SSI were also associated to in-hospital SSI. Additionally, only NNIS, pre-operative hospital
stay, use of drains, and antibiotic prophylaxis were associated with postdischarge SSI.
Conclusion: Our study provided information on risk factors for SSI in a large population in general
surgery setting in Italy. Standardized postdischarge surveillance detected 38.6% of all SSI. We also
compared risk factors for in-hospital and postdischarge SSI, thus providing additional information to that
of the current available literature. Finally, a large amount of postdischarge SSI were detected through
telephone interview. The evaluation of the cost-effectiveness of the telephone interview as a postdischarge
surveillance method could be an issue for further research.
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Background
Surgical site infections (SSI) remain a major clinical prob-
lem in terms of morbidity, mortality [1], length of stay
and hospital costs [2-4]. Nearly 60% of SSI diagnosis,
ranging from 21 to 100%, [5-9] occur after hospital dis-
charge and the trend increases as the length of postopera-
tive hospital stay is getting shorter and the number of one
day surgery procedures enlarges over time.
According to current literature, active SSI surveillance is
useful in reducing SSI incidence by surveillance-induced
infection control efforts [10-12]. However, although rep-
resenting a methodological tool of increasing importance
for its large impact on SSI rates [5,13-16], it also repre-
sents a methodological challenge for clinicians and epide-
miologists, because the patient is not constantly under
medical observation, and microbiological investigation
becomes difficult to perform after discharge.
Indeed, a matter of concern is the choice of the most effec-
tive postdischarge surveillance (PDS) methodology to
estimate SSI rates; actually, the incidence of postdischarge
SSI could depend on which of the different PDS method
is being performed. The authors of a recent systematic
review of PDS methods reported that no valid and reliable
method of SSI case ascertainment is available till now
[17]. Most of the studies on postdischarge SSI aimed also
to evaluate the associated risk factors, and interestingly,
they suggested that most of the predictors of in-hospital
SSI were not predictors of postdischarge SSI [7]. Particu-
larly, the composite National Nosocomial Infection Sur-
veillance (NNIS) risk score was found to be positively
correlated to the risk of inhospital SSI [18], whereas other
reports have documented a discrepancy between the pre-
dicted risk of infection by NNIS index score and the inci-
dence of postdischarge SSI [7,8].
A national prospective multicenter study was conducted
with the aim of assessing the incidence of both in-hospital
and postdisharge SSI, and the associated risk factors. We
aimed also to evaluate the performance of the NNIS risk
index in predicting SSI occurrence in the Italian Surgical
setting, and its validity in stratifying risk according to spe-
cific surgical procedures.
Methods
In 2002, a one-month, prospective national multicenter
surveillance study was conducted in General and Gyneco-
logical units of 48 Italian hospitals on 4,665 consecutive
patients undergoing the following surgical procedures:
hernia repair (n = 1,079; 23.1%), caesarean section (n =
1,050; 22.5%), cholecystectomy (n = 781;16.7%), breast
surgery (n = 436; 9.3%), colon surgery (n = 364; 7.8%),
gastric surgery (n = 165; 3.5%), abdominal hysterectomy
(n = 355; 7.6%), vaginal hysterectomy (n = 171;3.6%),
appendectomy (n = 238; 5.1%), vascular surgery (n = 16;
0.3%), and other minor interventions on genitourinary
tract (n = 10; 0.21%). The following 6 surgical procedures
included also the laparoscopic technique: cholecistec-
tomy (n = 438; 56%), appendectomy (n = 24; 10%),
colon surgery (n = 18; 4.9%), abdominal hysterectomy (n
= 15; 4.2%), hernia repair (n = 39; 3.6%), and gastric sur-
gery (n = 6; 3.6%). Table 1 summarizes the main charac-
teristics of the study population. All the above listed
procedures were included in the surveillance program.
One month before starting the study, for each participat-
ing center, referent infection control personnel, including
infection control practitioners, physicians, and nursing
staff attended a training meeting on how to collect infor-
mation and on patients' follow-up standardization.
In-hospital SSI
For each patient, infection control personnel used a ques-
tionnaire to collect information on demographic and
operation specific characteristics, and on SSI occurrence.
The following information was ascertained: demographic
characteristics, dates of admission and discharge, opera-
tion characteristics (i.e. type, date, and duration of the sur-
gical procedure, emergency or elective surgical
procedures, wound contamination class according to the
four-point wound infection score of the National
Research Council [19], American Society of Anesthesiolo-
gists (ASA) physical status score [20], any use of endo-
scopic surgical approach, any prosthesis implant),
antimicrobial perioperative prophylaxis, presence of
drains, occurrence, date of onset and type of in-hospital
SSI.
SSI diagnosis was performed using the Centers for Dis-
eases Control and Prevention (CDC) NNIS standardized
criteria [21]. According to these criteria, SSI are classified
as being either incisional or organ/space. Incisional SSI
are divided into those involving skin and subcutaneous
tissue (superficial incisional) and those involving deeper
Table 1: Population and operation specific characteristics
Total number of patients
Males (%)
4,665
1630 (34.9%)
Mean Median Range
Age, years 53 54 (18; 99)
ASA score 2 2 (1;5)
Length of preoperative stay, days 2 1 (0; 69)
Length of postoperative stay, days 64 ( 0 ;  3 7 7 )
Duration of intervention, hours 1.3 1 (0.2; 8.5)
NNIS index score 0 0 (-1*; 3)
-1 refers to interventions without risk factors for the NNIS index 
score, performed laparoscopically.
ASA = American Society of Anesthesiologists.
NNIS = National Nosocomial Infection Surveillance.BMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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soft tissue of surgical incision (deep incisional SSI).
Organ/space SSI involve any part of the anatomy other
than incised body wall layers, that was opened or manip-
ulated during an operation [21].
Moreover, the NNIS risk index score [22] was calculated
by assigning one point each for a contaminated wound
according to CDC definition [19], an ASA score ≥ 3, and
surgical procedures lasting longer than the NNIS-derived
75th percentile for the duration of the procedure; when-
ever the procedure was done laparoscopically, the NNIS
score was modified by subtracting 1 point, as more
recently suggested by Gaynes et al. [23]. The laparoscopic
surgical procedures without risk factors for the NNIS
index score, where included in a new risk category defined
as "M".
Postdischarge SSI
The last section of the questionnaire was dedicated to the
PDS, which reported information collected within 30
days after the operative procedure. Case ascertainment of
postdischarge SSI was carried out using the following
active surveillance methods: 1) a follow-up questionnaire,
that was given to the patient to be filled during follow-up
visits by the hospital infection control personnel; if the
patient was visited in another health care facility the phy-
sician was asked to fill out the questionnaire and to send
it back to the reference center; 2) patients who missed fol-
low-up visits were called by telephone by the infection
control nurses to be interviewed for any wound signs and
symptoms suggestive of SSI. In the first case, SSI were
identified by using the CDC criteria [21]. For patients sur-
veilled by telephone calling, SSI diagnosis was based on
criteria that are included in CDC definition of SSI, at least
for superficial infections. These criteria included one or
more of the following self-reported conditions: 1) puru-
lent wound secretion; 2) pain or tenderness, localized
swelling, redness, or heat at the surgical site.
To assess potential risk factors for SSI we performed a uni-
variate analysis which included the following variables:
gender, age, emergency interventions, NNIS score, any
prosthesis placement, preoperative hospital stay, use of
drains, any perioperative antimicrobial prophylaxis. All
the covariates with a p-value less than 0.1 at univariate
analysis were included in a multivariate conditional logis-
tic regression model.
Statistical analysis
Multivariate statistical analysis was performed using SPSS
(Version 11.0 Chigago Ilinois USA) statistical software;
the continuous variables were analyzed by calculating the
variance while the dichotomous variables were analyzed
by using the Χ2 test. Results were expressed in terms of
Odds Ratio (OR) with their respective 95% Confidence
Interval (CI).
Each participating institution (see in the acknowledgment
section) sought ethical clearance through their own Ethi-
cal Committee according to local regulations. Verbal
informed consent was obtained.
Results
Surgical site infections occurred in 241 (5.2%) of 4,665
patients. One-hundred-forty-eight SSI (61.4%) occurred
during hospital stay, and 93 (38.6%) within 30 days after
discharge. Of the 148 in-hospital SSI, 87, 37, and 24 were
classified as superficial, deep, and organ/space, respec-
tively. Post-discharge SSI observed at medical follow-up
were all superficial. Those SSI ascertained by telephone
calling were not classified according to the CDC classifica-
tion, due to lack of direct medical observation. However,
the telephone interviewers referred that in about 90% of
cases SSI could be classified as superficial.
Table 2 reports the frequencies of SSI according to surgical
procedure and NNIS risk index category. If excluding the
procedures with unknown PDS status, the highest SSI
incidence rates were observed in colon surgery (18.9%),
gastric surgery (13.6%), and appendectomy (8.6%); the
remaining surgical procedures had lower and similar SSI
rates (range 3.2–4%).
When calculating the OR of SSI for each NNIS risk index
category, significant differences were observed between
NNIS index category 0 and 1 for appendectomy: OR
24.38, 95% CI 3.21–510.30; p < 0.001, and for abdomi-
nal hysterectomy: OR 3.74, 95% CI 1.34–10.62; p =
0.003, and between NNIS index category M and >M for
cholecistectomy: NNIS score 0: OR 3.46; 95% CI
1.00–13.06; p = 0.026; NNIS score 1: OR 4.68; 95% CI
1.29–18.41; p = 0.005; NNIS score 2 + 3: OR 5.15; 95% CI
1.04–25.39; p = 0.012.
There was no significant difference between SSI rates in
laparoscopic and open cholecistectomy (15/438; 3.4% vs.
15/339; 4.4%; OR 0.77; 95% CI 0.35–1.68; p = 0.473).
For the other surgical procedures which also used the
laparoscopic technique (i.e. gastric surgery, appendec-
tomy, colon surgery, hernia repair, and abdominal hyster-
ectomy), differences among the SSI rates between NNIS
index category M and >M were not statistically significant.
We found that 4,486 out of 4,665 enrolled patients,
excluding those who developed an in-hospital SSI (n =
148), and those with a postoperative in-hospital stay
longer than 30 days (n = 31), were eligible for PDS. A total
of 4,228/4,486 (94.2%) patients underwent PDS, whereas
258 (5.8%) patients were lost to follow-up. One hundredBMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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and eighty-four questionnaires were filled and returned
back to the reference center; telephone interviews were
carried out for the remaining 4,041 patients. Sixty-two
(66.7%) and 31 (33.3%) of 93 postdischarge SSI were
detected through telephone interview and questionnaire
survey, respectively.
At univariate analysis, age ≥ 55 years, emergency interven-
tions, NNIS score > 0, use of prosthesis, pre-operative hos-
pital stay > 1 day, and use of drains resulted significantly
associated with SSI occurrence. At multivariate analysis,
emergency interventions, NNIS score > 0, pre-operative
hospital stay > 1 day, and use of drains remained signifi-
cantly associated with SSI occurrence (Table 3).
When stratifying risk factors for in-hospital and postdis-
charge SSI, we found that those factors that were signifi-
cantly associated for total SSI, were also associated for in-
hospital SSI. However, if considering postdischarge SSI,
only NNIS >1, pre-operative hospital stay >1, use of
drains, and antibiotic prophylaxis were associated with
postdischarge SSI (Table 4).
Moreover, clean or clean/contaminated operations such
as breast surgery, caesarean section, cholecistectomy, and
hernia repair had postdischarge SSI rates from 1.2 to 3.3
times higher than those observed during the hospital stay.
On the other hand, we found that contaminated opera-
tions had higher in-hospital SSI rates (Table 5).
Discussion
In our study we used the NNIS methodology in order to
standardize and compare our data with those published
in the current literature. Indeed, according to a retrospec-
tive review on European studies [4], the true rate of SSI is
actually unknown in Europe and is likely to have been
underestimated as a consequence of the variability of data
collection, surveillance methods, and type of surgical pro-
cedures that are investigated.
In the present study, the overall SSI incidence rate was
5.2% which is lower than that reported in other Italian
(range 5.4%–12.8%) [24-26,9], and European [7,15]
studies including the European Surveillance of Surgical
site Infections HELICS – Improving patient Safety in
Europe (IPSE) network [27], which used the NNIS defini-
tions and surveillance methodology. In particular, if con-
sidering only general, gynecological (including caesarean
section), and vascular surgery interventions, European SSI
rates are higher and globally range from 6.34% to 14.8%
[7,15].
However, for some types of interventions our SSI rates are
higher than those reported in the literature. In our study,
we found that the highest SSI incidence were observed in
colon surgery (18.9%), gastric surgery (13.6%) and
appendectomy (8.6%). These rates are about two fold
higher than those reported by other national and Euro-
pean studies, and by the U.S. NNIS reports [10,9,24,28].
Moreover, the rates of SSI after cholecystectomies was very
high, as compared to those mentioned in the HELICS net-
work [27] These differences could depend on type, accu-
racy, and distribution of PDS methods [10,15,24,10], on
losses in follow-up, and on the impossibility to assess the
postdischarge response validity.
In our study, we found that emergency interventions,
NNIS index score, and pre-operative hospital stay were
independently associated to overall SSI occurrence. These
findings are not discordant with previous reports of the 
Table 2: Frequencies of SSI§ according to type of intervention and NNIS§§ index category.
Surgical procedure* Total** number of 
procedures (n = 4,386)
N SSI (%) N SSI (%) according to NNIS index category
M0 12  +  3
Breast surgery 406 13 (3.2%) - 10/281 (3.5%) 2/111 (1.8%) 1/10 (10%)
Cesarean section 1012 27 (2.6%) - 20/775 (2.6%) 6/218 (2.7%) 0/8 (0%)
Cholecistectomy 740 30 (4%) 4/287 (1.4%) 11/236 (4.6%) 9/145 (6.2%) 4/59 (6.7%)
Gastric surgery 147 20 (13.6%) 1/3 (33.3%) 3/50 (6%) 1/63 (1.6%) 4/23 (17.4%)
Appendectomy 221 19 (8.6%) 0/16 (0%) 1/108 (0.9%) 13/76 (17.1%) 3/18 (16.6%)
Colon surgery 338 64 (18.9%) 2/4 (50%) 14/70 (20%) 24/151 (15.9%) 22/109 (20.2%)
Hernia repair 1014 41 (4%) 1/19 (5.3%) 20/641 (3.1%) 15/283 (5.3%) 4/46 (8.7%)
Abdominal hysterectomy 346 21 (6.1%) 1/12 (8.3%) 7/217 (3.2%) 11/91 (12.1%) 1/20 (5%)
Vaginal hysterectomy 162 6 (3.7%) - 3/117 (2.5%) 3/41 (7.3%) 0/2 (0%)
§ Surgical site infections.
§§National Nosocomial Infection Surveillance index category.
*Cardiovascular and other minor interventions are not reported because the denominator was too little (n = 21) to be included in statistical 
analysis.
** The procedures with no postdischarge surveillance (258) were not included.
M: no risk factor for NNIS index score plus laparoscopical procedure (NNIS = -1).BMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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literature [18,22,24]; however, we provided additional
details that deserve particular attention.
First, when stratifying by NNIS index category according
to operative procedure, we found no significant differ-
ences between NNIS index category, for most of the pro-
cedures except for appendectomy, abdominal
hysterectomy (Table 2). Regarding laparoscopic proce-
dures, it should be noticed that the small number of these
procedures in some interventions was a limiting factor in
the statistical analysis.
Actually, conflicting data are reported in the literature
about the predictive power of the NNIS index score, at
least for specific interventions such as cesarean sections
and breast interventions [10,8,29-31]. Furthermore, in
agreement with our findings, in other reports [32,22]
NNIS index score did not perform well for single surgical
procedures, but it was found to perform better when tak-
ing into account a group of different interventions. On the
contrary, according to the HELICS-IPSE most recent
reports, the SSI increases with the NNIS index score, even
for caesarean sections [27]. A possible explanation of our
finding may be that the NNIS index score underestimates
SSI incidence as it represents an inpatient risk score which
does not include postdischarge surveillance variables.
Therefore, NNIS index score may not represent a suitable
tool for the SSI risk evaluation in particularly for clean
interventions where SSI are likely to be detected during
postdischarge surveillance, probably due to anticipated
hospital discharge.
Table 3: Risk factors for surgical site infection (SSI).
Univariate analysis Multivariate analysis
Variable Total § No. SSI/total§ Odds Ratio (95% CI^^) p* Odds Ratio (95% CI^^) p*
Gender
Male 4,406 97/1521 1.30 (0.99–1.70) 0.054 1.13 (0.83–1.55) 0.429
Female 144/2,885
Age, years
18–36 4,172 35/1,101 1
37–54 45/1,004 1.43 (0.89–2.30) 0.118 1.11 (0.72–1.69) 0.635
55–70 67/1,107 1.96 (1.27–3.04) 0.001 0.91 (0.63–1.31) 0.622
>70 88/960 3.07 (2.02–4.69) <0.001 1.51 (0.91–2.51) 0.113
Emergency Interventions
Yes 4,396 69/944 1.50 (1.11–2.03) 0.005 1.73 (1.22–2.44) 0.002
No 172/3,452
NNIS score
M 4,330 8/341 1
0 90/2,507 1.55 (0.72–3.48) 0.237 1.18 (0.77–1.82) 0.441
1 90/1,182 3.43 (1.59–7.71) <0.001 1.82 (1.14–2.90) 0.012
2 + 3 41/300 6.59 (2.91–15.50) <0.001 3.34 (1.41–7.93) 0.006
Prosthesis
Yes 4,393 23/762 0.60 (0.39–0.91) 0.011 0.62 (0.38–1.04) 0.07
No 218/3,631
Pre-operative hospital stay, days
4,337 130/3,136 2.15 (1.63–2.83) <0.001 1.45 (1.06–1.98) 0.02
0–1 102/1,201
>1
Drains
No 4,406 97/2,894 1
1–3 days 31/702 3.04 (2.31–3.99) <0.001 2.39 (0.65–1.65) <0.001
>3 days 111/810 4.58 (3.41–6.15) <0.001 2.17 (1.38–3.43) <0.001
Perioperative prophylaxis
Yes 4,406 213/3,857 0.92 (0.60–1.40) 0.684 - -
No 28/549
§ total number of procedures considered not equal to the study cohort (n = 4,665) for missing data; also patients with missing data for SSI 
occurrence during postdischarge (n = 258) were excluded from the analysis.
^^ 95% confidence intervals (CI).
* p-value.
M no risk factor for NNIS index score + laparoscopical procedure (NNIS = -1).
NNIS = National Nosocomial Infection Surveillance.BMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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Second, we observed that the use of drains was signifi-
cantly associated with SSI occurrence independently of
the length of drainage (i.e., 1–3 or < 3 days); additionally,
we found that length of preoperative hospital stay > 1 day
was associated with a significant risk of SSI. Of note, pre-
operative hospital may be independent from one day sur-
gery procedures. This finding underlines the importance
of performing day surgery procedures, whenever possible.
Third, we found the SSI rate among laparoscopic cholecis-
tectomy interventions was lower than the open technique
but did not reached a statistical significance, contrarily to
what reported in other reports [33].
In the present study, we also aimed to provide informa-
tion on postdischarge SSI. Interestingly, we found that
38.6% of SSI were diagnosed after discharge; this rate is
comparable to the 34.8% reported by Fiorio et al. [24] in
Italian general surgery inpatients, although other similar
surveillance studies [7-9] found considerably higher post-
discharge SSI rates, ranging from 34.8 to 60%. We also
observed that the higher ratio of postdischarge/in-hospi-
Table 4: Risk factors for in-hospital and postdischarge surgical site infection (SSI).
In-hospital period Post-discharge period
Variable Total § No. SSI/total§ Odds Ratio (95% CI^^) Total§S No. SSI/total §§ Odds Ratio (95% CI^^)
Gender
Male 4,665 67/1,625 1.57 (1.12–2.21)* 4,258 30/1,454 0.92 (0.58–1.45)#
Female 81/3,040 63/2,804
Age (years)
18–36 15/1,163 1 20/1,086 1
37–54 4,420 26/1,057 1.93 (0.98–3.84)# 4,027 19/978 1.06 (0.54–2.08)#
55–70 44/1,162 3.01 (1.62–5.69)* 23/1,063 1.18 (0.62–2.25)#
>70 60/1,038 4.70 (2.58–8.68)* 28/900 1.71 (0.93–3.18)#
Emergency Intervention
4,655 4,258
Yes 51/1,002 1.97 (1.37–2.82)* 18/903 0.89 (0.51–1.53)#
No 97/3,653 75/3,355
NNIS score §
4/358 1 4/336 1
M 38/2,621 1.30 (0.44–4.32)# 52/2,459 1.79 (0.62–5.87)#
4,579 4,166
0 65/1,260 4.81 (1.67– 25/1,108 1.92 (0.63–6.54)#
1 30/340 15.63)* 11/263 3.62 (1.05–
2 + 3 11.42 (3.86–38)* 13.65)*
Prosthesis
Yes 4,652 6/801 0.20 (0.08–0.46)* 4,245 17/756 1.03 (0.58–1.80)#
No 142/3,851 76/3,489
Pre-operative hospital 
stay (days)
4,589 4,196
72/3,300 58/3,064
0–1 69/1,289 2.54 (1.79–3.60)* 33/1,132 1.56 (0.99–2.45)*
>1
Drains
No 41/3,045 1 56/2,853 1
1–3 days 4,665 19/764 1.87 (1.04–3.33)* 4,261 12/686 0.89 (0.45–1.72)#
>3 days 88/856 8.40 (5.66–12.48)* 23/722 1.64 (0.97–2.75)*
Perioperativ e antibiotic 
prophylaxis
4,665 4,258
Yes 139/4,071 0.44 (0.21–0.89)* 74/3,718 1.80 (1.04–3.07)*
No 9/594 19/540
§ total number of procedures surveilled during hospital stay not equal to the study cohort (n = 4,665) for missing data.
NNIS = National Nosocomial Infection Surveillance.
§§ total number of interventions surveilled during post-discharge, does not include missing data for SSI occurrence during postdischarge (n = 258), 
and patients with in-hospital SSI (n = 148) or with postoperative hospital stay ≥ 30 days (n = 25).
^^ 95% confidence intervals.
* p-value < 0.05.
# p value not significant.
M: no risk factor + endoscopical procedure.BMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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tal SSI was found in clean interventions, as evidenced in
other recent reports [7,9,15]. In particular, breast inter-
ventions, and cesarean sections had higher SSI incidence
rates during the postdischarge period, ie 2.4% and 1.8%,
respectively (Table 5). A possible explanation to this find-
ing could be the shorter postoperative stay which charac-
terizes the above mentioned interventions. Our finding
should advice infection control practitioners of the need
for improving PDS surveillance methods for targeted sur-
gical procedures.
Moreover, we were able to provide a better insight on the
risk factors for postdischarge SSI, for which information
from the literature is scant. Indeed, in our study we found
that most predictors of in-hospital SSI were not predictors
of postdischarge SSI, as already suggested by Delgado-
Rodriguez et al. [7] Only NNIS >1, preoperative hospital
stay, and antibiotic prophylaxis were significantly associ-
ated with postdischarge diagnosis. The presence of drains
was marginally predictive of postdischarge SSI, and only if
drains remained for more than 3 days. These data are dis-
cordant with those of other similar studies [7,5] that failed
to identify risk factors for postdischarge SSI, particularly
on what concerns the validity of the NNIS index score.
Another important finding of our study is the importance
of telephone interview for the detection of postdischarge
SSI. Indeed, almost 60% of postdischarge SSI were diag-
nosed by telephone interview, which underlines the
importance of this cost-effective surveillance methodol-
ogy for SSI detection. On the other hand, we are aware of
the little supporting evidence regarding the validity and
reliability of self-reported diagnosis, as suggested by other
reports [17].
Our study has some limitations including the lack of other
possible host-related risk factors to be included in multi-
variate analysis such as body mass index, malnutrition,
diabetes, cancer, immunosuppressive drugs. Moreover,
another limitation of our study depends on the lack of
standardized post-discharge surveillance methodologies,
which could affect the validity of the post-discharge SSI
rate. In fact, accurate, and standardized methods for defin-
ing and monitoring post-discharge SSI are needed to cor-
rect assess infection rates.
Additionally, our study did not provide any information
regarding the cost-effectiveness of telephone post-dis-
charge surveillance, and on the economic impact of post-
discharge SSI on public health. We suggest to evaluate the
cost-effectiveness of such postdischarge method for fur-
ther research.
Finally, although most of the postdischarge SSI were
superficial, we think that looking at them could make
sense in terms of economic impact on public health as evi-
denced by recent studies [34,35].
Conclusion
Our study provided information on risk factors for SSI
occurrence in a large population in general surgery setting
in Italy. Moreover, standardized postdischarge surveil-
lance methodology was carried out, which detected
38.6% of all SSI. We were also able to compare risk factors
for in-hospital and postdischarge SSI, thus providing
additional information to that of the current available lit-
erature. Particularly, we found that NNIS >1, preoperative
hospital stay >1 day, use of drains, and antibiotic prophy-
laxis were significantly associated to postdischarge SSI
diagnosis. Moreover, a large amount of postdischarge SSI
were detected through telephone interview, which under-
lines the importance of this PDS methodology for its cost-
effectiveness.
Table 5: Rates of in-hospital and postdischarge surgical site infections (SSIs) according to type of intervention.
Surgical procedure N°Postdischarge SSI/total* (n = 
4,407)
In-hospital SSI/total (n = 4,665) Posdischarge/In-hospital ratio
Vascular surgery 0/16 (0%) 0/16 (0%) -
Breast surgery 10/406 (2.4%) 3/437 (0.7%) 3.4
Cesarean section 19/1012 (1.8%) 8/1050 (0.7%) 2.5
Cholecistectomy 16/740 (2.1%) 14/781 (1.8%) 1.2
Gastric surgery 5/147 (3.4%) 15/165 (9.1%) 0.4
Appendectomy 3/221 (1.4%) 16/238 (6.7%) 0.2
Colon surgery 6/338 (1.8%) 58/364 (15.9%) 0.1
Hernia repair 23/1014 (2.3%) 18/1079 (1.6%) 1.4
Abdominal hysterectomy 8/346 (2.3%) 13/355 (3.7%) 0.6
Vaginal hysterectomy 3/162 (1.8%) 3/171 (1.7%) 1
Other genitourinary surgery 1/5 (20%) 0/5 (0%) -
* The procedures with unknown PDS status (n = 258) were not included.BMC Infectious Diseases 2008, 8:34 http://www.biomedcentral.com/1471-2334/8/34
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